These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28134226)

  • 81. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
    Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
    Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study.
    Grimm W; Glaveris C; Hoffmann J; Menz V; Mey N; Born S; Maisch B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2551-6. PubMed ID: 9825383
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].
    Ikama SM; Makani J; Ellenga-Mbolla B; Ondze-Kafata LI; Gombet TR; Kimbally-Kaky G
    Pan Afr Med J; 2017; 27():31. PubMed ID: 28761607
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The implantable cardiac defibrillator: indications and complications].
    Simmers TA; Bracke FA
    Ned Tijdschr Geneeskd; 2013; 157(47):A6328. PubMed ID: 24252404
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inferior and anterior QRS fragmentation have different prognostic value in patients who received an implantable defibrillator in primary prevention of sudden cardiac death.
    Vandenberk B; Robyns T; Goovaerts G; Van Soest S; Floré V; Garweg C; Van Huffel S; Ector J; Willems R
    Int J Cardiol; 2017 Sep; 243():223-228. PubMed ID: 28747026
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Red cell distribution width predicts death and appropriate therapy in patients with implantable cardioverter defibrillator: A simple measurement with prognostic value in a variety of diseases, may help in better selection of patients who will benefit the most from this device.
    Dabbah S; Chertin L; Khateeb A; Rosenfeld I; Suleiman M; Halabi M
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1384-1388. PubMed ID: 29067703
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An interactive assistant for patients with cardiac implantable electronic devices: A study protocol of the LUCY trial.
    Michalik J; Cacko A; Poliński J; Pawlik K; Tataj E; Gawałko M; Opolski G; Grabowski M
    Medicine (Baltimore); 2018 Sep; 97(39):e12556. PubMed ID: 30278555
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effectiveness of Medtronic CareLink Express System in identifying patients with high-energy electrotherapy devices requiring clinically significant intervention.
    Grabowski M; Sadecka S; Cacko A; Michalak M; Blicharz L; Balsam P; Opolski G
    Cardiol J; 2018; 25(1):81-86. PubMed ID: 28653315
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.
    Shenthar J; Bohra S; Jetley V; Vora A; Lokhandwala Y; Nabar A; Naik A; Calambur N; Gupta SB
    Indian Heart J; 2016; 68(1):68-71. PubMed ID: 26896270
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.
    Barra S; Providência R; Boveda S; Duehmke R; Narayanan K; Chow AW; Piot O; Klug D; Defaye P; Gras D; Deharo JC; Milliez P; Da Costa A; Mondoly P; Gonzalez-Panizo J; Leclercq C; Heck P; Virdee M; Sadoul N; Le Heuzey JY; Marijon E
    Heart; 2018 Sep; 104(18):1529-1535. PubMed ID: 29540431
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Importance of monitoring zones in the detection of arrhythmias in patients with implantable cardioverter-defibrillators under remote monitoring.
    Aguiar Rosa S; Silva Cunha P; Lousinha A; Valente B; Delgado AS; Pimenta R; Brás M; Coutinho Cruz M; Portugal G; Viveiros Monteiro A; Oliveira M; Cruz Ferreira R
    Rev Port Cardiol (Engl Ed); 2019 Jan; 38(1):11-16. PubMed ID: 30686652
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion.
    Bettin M; Rath B; Ellermann C; Leitz P; Reinke F; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2019 Jan; 108(1):16-21. PubMed ID: 29948287
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Telemetric follow-up of implantable electronic cardiac devices : Optimisation of care in clinical practice].
    Bosch R; Mutscher I
    Herzschrittmacherther Elektrophysiol; 2017 Sep; 28(3):260-267. PubMed ID: 28812138
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Activation of remote monitoring for cardiac implantable electronic devices: small dog for tall weeds.
    D'Ancona G; Safak E; Senges J; Hochadel M; Nguyen VL; Perings C; Jung W; Spitzer S; Eckardt L; Brachmann J; Seidl K; Hink HU; Ince H; Ortak J
    Clin Res Cardiol; 2017 Oct; 106(10):833-839. PubMed ID: 28593341
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Malignant ventricular arrhythmias in alcoholic cardiomyopathy.
    Guzzo-Merello G; Dominguez F; González-López E; Cobo-Marcos M; Gomez-Bueno M; Fernandez-Lozano I; Millan I; Segovia J; Alonso-Pulpon L; Garcia-Pavia P
    Int J Cardiol; 2015 Nov; 199():99-105. PubMed ID: 26188828
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis.
    Stolfo D; Albani S; Savarese G; Barbati G; Ramani F; Gigli M; Biondi F; Dal Ferro M; Zecchin M; Merlo M; Sinagra G
    Int J Cardiol; 2020 May; 307():75-81. PubMed ID: 32067834
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy.
    Mazur M; Wang F; Hodge DO; Siontis BL; Beinborn DS; Villarraga HR; Lerman A; Friedman PA; Herrmann J
    JACC Clin Electrophysiol; 2017 Feb; 3(2):139-150. PubMed ID: 29759386
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Implantable cardioverter defibrillators and cellular telephones: is there any interference?
    Occhetta E; Plebani L; Bortnik M; Sacchetti G; Trevi G
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):983-9. PubMed ID: 10456625
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The new ESC guidelines on the management of ventricular tachyarrhythmias : Implications for daily practice].
    Könemann H; Frommeyer G; Zeppenfeld K; Eckardt L
    Herz; 2023 Feb; 48(1):3-14. PubMed ID: 36441174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.